BDX · News · 20260807N

Guidance / Outlook

BECTON DICKINSON & CO · 2026-08-07 · Importance 51 · Surprise 60

BD raised its fiscal 2026 adjusted diluted EPS guidance midpoint to $12.67 and expects revenue growth toward the high end of its previously stated range. Third-party reporting attributed the improved outlook to stronger demand for drug-delivery devices, surgical equipment, and other growth platforms. Management also expects to offset potential cost increases from volatile oil prices affecting resin and molded plastics through pricing actions.

Key facts

• BD attributed raising the lower end of its annual adjusted profit forecast to strong demand for its drug-delivery devices and surgical equipment. source